ORIGINAL RESEARCH
Accepted on 30 Aug 2025
SLFN11 Expression correlates with immune microenvironment and predicts prognosis in melanoma
doi 10.3389/fimmu.2025.1607056
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Integrating Molecular Mechanisms, Immunotherapy, and Drug Sensitivity in Cancer Immunology and Oncology
Integrating Molecular Mechanisms, Immunotherapy, and Drug Sensitivity in Cancer Immunology and Oncology
22k
Total downloads
84k
Total views and downloads
Articles
ORIGINAL RESEARCH
Accepted on 14 Aug 2025
Physicochemical and biological characterization of a bispecific antibody in a CrossMab/KIH format that targets EGFR and VEGF-A
doi 10.3389/fimmu.2025.1659966
- 218 views
MINI REVIEW
Accepted on 12 Aug 2025
Sepsis-Driven Metabolic Reprogramming Shapes Cancer Immunotherapy Efficacy, Metastatic Potential, and Drug Sensitivity
doi 10.3389/fimmu.2025.1642477
- 131 views
ORIGINAL RESEARCH
Published on 24 Jul 2025
Identification of a coagulation-related classification and signature that predict disease heterogeneity for colorectal cancer and pan-cancer patients
doi 10.3389/fimmu.2025.1572701
- 842 views
ORIGINAL RESEARCH
Published on 15 Jul 2025
Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer
doi 10.3389/fimmu.2025.1593639
- 1,317 views
ORIGINAL RESEARCH
Published on 14 Jul 2025
Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study
doi 10.3389/fimmu.2025.1611696
- 1,194 views
ORIGINAL RESEARCH
Published on 26 Jun 2025
Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model
doi 10.3389/fimmu.2025.1602898
- 1,776 views
ORIGINAL RESEARCH
Published on 24 Jun 2025
Taurine-mediated metabolic immune crosstalk indicates and promotes immunosuppression with anti-PD-1 resistance in bladder cancer
doi 10.3389/fimmu.2025.1618439
- 1,844 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Jun 2025
Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status
doi 10.3389/fonc.2025.1596156
- 1,165 views
REVIEW
Published on 21 May 2025
Dissecting the dual role of OTU family proteins in tumor progression and immune escape
doi 10.3389/fimmu.2025.1544341
- 1,271 views
ORIGINAL RESEARCH
Published on 13 May 2025
Glypican-3 regulated epithelial mesenchymal transformation-related genes in osteosarcoma: based on comprehensive tumor microenvironment profiling
doi 10.3389/fimmu.2025.1566061
- 1,187 views
REVIEW
Published on 17 Apr 2025
Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery
doi 10.3389/fimmu.2025.1584087
- 2,190 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore